Mavik and Vesicare drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mavik (trandolapril) and Vesicare (solifenacin succinate). Common drug interactions include atrial fibrillation among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Mavik and Vesicare. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Mavik?

Mavik has active ingredients of trandolapril. It is often used in high blood pressure. eHealthMe is studying from 3,145 Mavik users. Check the latest studies of Mavik.

What is Vesicare?

Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,656 Vesicare users. Check the latest studies of Vesicare.

On Jul, 10, 2026

13 people who take Mavik and Vesicare together, and have interactions are studied.

What are the common drug interactions of Mavik and Vesicare, by gender? *:

female:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Dysgeusia (disorder of the sense of taste)
Dyspnoea (difficult or laboured respiration)
Flushing (the warm, red condition of human skin)
Headache (pain in head)
Heart rate increased
Hypoaesthesia (reduced sense of touch or sensation)
Infusion related reaction
Malaise (a feeling of general discomfort or uneasiness)
Oxygen saturation decreased

male:

Fall
Blood disorder
Asthenia (weakness)
Back pain
Balance disorder
Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
Burning sensation
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

What are the common drug interactions of Mavik and Vesicare, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Metabolic syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease)
Type 2 diabetes mellitus
Vision blurred

50-59:

n/a

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Pain
Oxygen saturation decreased
Palpitations (feelings or sensations that your heart is pounding or racing)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pharyngeal mass
Sinus congestion (blockage of sinus)
Throat irritation
Throat tightness
Tinnitus (a ringing in the ears)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 30.77%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 30.77%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 23.08%
High Blood Cholesterol: 3 people, 23.08%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 15.38%
Sinus Disorder (disease of sinus): 1 person, 7.69%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 7.69%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 7.69%
Indigestion: 1 person, 7.69%
Herpes Zoster: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Mavik and Vesicare?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously